Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glu...

[1]  John A Cidlowski,et al.  Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. , 2005, Molecular cell.

[2]  M. Takigawa,et al.  Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3'-kinase signaling pathway. , 2005, Endocrinology.

[3]  K. Dahlman-Wright,et al.  Identification of Endogenous Glucocorticoid Repressed Genes Differentially Regulated by a Glucocorticoid Receptor Mutant Able to Separate between Nuclear Factor-κB and Activator Protein-1 Repression , 2004, Molecular Pharmacology.

[4]  E. Canalis,et al.  Mechanisms of Glucocorticoid Action in Bone , 2002, Current osteoporosis reports.

[5]  E. Solito,et al.  Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  Amjad Ali,et al.  Selective glucocorticoid receptor nonsteroidal ligands completely antagonize the dexamethasone mediated induction of enzymes involved in gluconeogenesis and glutamine metabolism , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  H. Garside,et al.  Glucocorticoid Ligands Specify Different Interactions with NF-κB by Allosteric Effects on the Glucocorticoid Receptor DNA Binding Domain* , 2004, Journal of Biological Chemistry.

[8]  L. Ou,et al.  Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. , 2004, The Journal of allergy and clinical immunology.

[9]  E. Morand,et al.  Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids. , 2004, Arthritis and rheumatism.

[10]  T. Heinzel,et al.  Negative glucocorticoid receptor response elements and their role in glucocorticoid action. , 2004, Current pharmaceutical design.

[11]  J. Mullol,et al.  Glucocorticoid Receptor Isoforms α and β in in Vitro Cytokine-induced Glucocorticoid Insensitivity , 2004 .

[12]  Y. An,et al.  Is there an inhibitory effect of COX-2 inhibitors on bone healing? , 2004, Pharmacological research.

[13]  Takao Shimizu,et al.  Regulatory mechanism and physiological role of cytosolic phospholipase A2. , 2004, Biological & pharmaceutical bulletin.

[14]  J. Iwamoto,et al.  Effects of vitamin K2 on osteoporosis. , 2004, Current pharmaceutical design.

[15]  C. R. Yates,et al.  Systemic Inflammation‐Associated Glucocorticoid Resistance and Outcome of ARDS , 2004, Annals of the New York Academy of Sciences.

[16]  G. Hager,et al.  Subnuclear Trafficking and Gene Targeting by Steroid Receptors , 2004, Annals of the New York Academy of Sciences.

[17]  J. Cidlowski,et al.  The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms , 2004, Annals of the New York Academy of Sciences.

[18]  M. Garabedian,et al.  Modulation of Glucocorticoid Receptor Function via Phosphorylation , 2004, Annals of the New York Academy of Sciences.

[19]  Qiang Wu,et al.  Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. , 2003, Genome research.

[20]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[21]  J. Cidlowski,et al.  Nuclear Factor-κB and Glucocorticoid Receptors , 2004 .

[22]  J. Mullol,et al.  Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity. , 2004, American Journal of Respiratory and Critical Care Medicine.

[23]  Shumei Yang,et al.  Glucocorticoids and vascular reactivity. , 2004, Current vascular pharmacology.

[24]  Miguel Ángel Martínez,et al.  Influence of Cortisol Status on Leptin Secretion , 2004, Pituitary.

[25]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. , 2004, The Journal of clinical investigation.

[26]  K. Asadullah,et al.  Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Iñiguez-Lluhí,et al.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Wit,et al.  Systemic and local regulation of the growth plate. , 2003, Endocrine reviews.

[29]  D. Kontoyiannis,et al.  Glucocorticoids and invasive fungal infections , 2003, The Lancet.

[30]  S. Elmore,et al.  The pursuit of differentiated ligands for the glucocorticoid receptor. , 2003, Current topics in medicinal chemistry.

[31]  W. Vedeckis,et al.  Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines. , 2003, Biochemistry.

[32]  J. Dean,et al.  Control of the expression of inflammatory response genes. , 2003, Biochemical Society symposium.

[33]  G. Colice,et al.  Inhaled corticosteroids: past lessons and future issues. , 2003, The Journal of allergy and clinical immunology.

[34]  D. Trence.  Management of patients on chronic glucocorticoid therapy: an endocrine perspective. , 2003, Primary care.

[35]  K. Cutroneo.  How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis , 2003, Journal of cellular biochemistry.

[36]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[37]  G. Haegeman,et al.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. , 2003, Endocrine reviews.

[38]  Jonathan Greer,et al.  The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain , 2003, Journal of Biological Chemistry.

[39]  G. Cooper,et al.  The epidemiology of autoimmune diseases. , 2003, Autoimmunity reviews.

[40]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[41]  J. Garvin,et al.  Cardiovascular and renal control in NOS-deficient mouse models. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[42]  T. Archer,et al.  Chromatin remodeling by nuclear receptors , 2003, Chromosoma.

[43]  T. Salo,et al.  Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin , 2003, The British journal of dermatology.

[44]  J. Kemp.  Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma. , 2003, Clinical therapeutics.

[45]  G. R. Dodge,et al.  Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes , 2003, Inflammation Research.

[46]  E. Sternberg,et al.  Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.

[47]  M. Paul-Clark,et al.  The annexin-1 knockout mouse: what it tells us about the inflammatory response. , 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[48]  J. Saklatvala,et al.  Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38 , 2002, Molecular and Cellular Biology.

[49]  Khusru Asadullah,et al.  Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.

[50]  C. Breuner,et al.  Plasma binding proteins as mediators of corticosteroid action in vertebrates. , 2002, The Journal of endocrinology.

[51]  D. Michel,et al.  Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. , 2002, Endocrinology.

[52]  D. DeFranco,et al.  Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity. , 2002, Molecular endocrinology.

[53]  T. Tanabe,et al.  Cyclooxygenase isozymes and their gene structures and expression. , 2002, Prostaglandins & other lipid mediators.

[54]  T. Willson,et al.  Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition , 2002, Cell.

[55]  A. Cato,et al.  Rapid Actions of Steroid Receptors in Cellular Signaling Pathways , 2002, Science's STKE.

[56]  I. Chikanza.  Mechanisms of Corticosteroid Resistance in Rheumatoid Arthritis , 2002, Annals of the New York Academy of Sciences.

[57]  J. O'Callaghan,et al.  Neuroendocrine aspects of the response to stress. , 2002, Metabolism: clinical and experimental.

[58]  M. Perretti,et al.  Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids , 2002, Annals of the New York Academy of Sciences.

[59]  M. Moskowitz,et al.  Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase , 2002, Nature Medicine.

[60]  D. Gilroy,et al.  Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells , 2002, British journal of pharmacology.

[61]  S. Umland,et al.  Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. , 2002, Pulmonary pharmacology & therapeutics.

[62]  I. Chikanza.  Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. , 2002, Annals of the New York Academy of Sciences.

[63]  O. Kassel,et al.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.

[64]  R. Kaufmann,et al.  Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes. , 2001, The Journal of investigative dermatology.

[65]  J. Cidlowski,et al.  Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids* , 2001, The Journal of Biological Chemistry.

[66]  S. Rivest.  How circulating cytokines trigger the neural circuits that control the hypothalamic–pituitary–adrenal axis , 2001, Psychoneuroendocrinology.

[67]  J. Cidlowski,et al.  Molecular identification and characterization of a and b forms of the glucocorticoid receptor. , 2001, Molecular endocrinology.

[68]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[69]  J. Cidlowski,et al.  Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  E. Choi,et al.  Inhibition of Cytosolic Phospholipase A2 by Annexin I , 2001, The Journal of Biological Chemistry.

[71]  A. Wanner,et al.  Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. , 2001, Journal of applied physiology.

[72]  R. Gagliardo,et al.  Is there a role for glucocorticoid receptor beta in asthma? , 2000, Respiratory research.

[73]  F. Antonicelli,et al.  CREB is involved in mouse annexin A1 regulation by cAMP and glucocorticoids. , 2001, European journal of biochemistry.

[74]  J. Mullol,et al.  Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. , 2001, American journal of respiratory cell and molecular biology.

[75]  K. Yamamoto,et al.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.

[76]  A. Ahluwalia,et al.  The Microcirculation and Inflammation: Site of Action for Glucocorticoids , 2000, Microcirculation.

[77]  Mitch We.  Mechanisms accelerating muscle atrophy in catabolic diseases. , 2000 .

[78]  I. Danta,et al.  Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. , 2000, American journal of respiratory and critical care medicine.

[79]  S. Werner,et al.  Glucocorticoid-regulated gene expression during cutaneous wound repair. , 2000, Vitamins and hormones.

[80]  J. Cidlowski,et al.  Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. , 1999, Endocrine reviews.

[81]  B. Lipworth.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.

[82]  M. Ullian.  The role of corticosteriods in the regulation of vascular tone. , 1999, Cardiovascular research.

[83]  M. Perretti,et al.  Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[84]  R. Flower,et al.  IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. , 1998, Cytokine.

[85]  I. Adcock,et al.  Transcription factors and asthma. , 1998, The European respiratory journal.

[86]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[87]  Y. Wada,et al.  Glucocorticoid induced the expression of mRNA and the secretion of lipocortin 1 in rat astrocytoma cells , 1997, Brain Research.

[88]  R. Eskay,et al.  The Protective Role of the Hypothalamic‐Pituitary‐Adrenal Axis against Lethality Produced by Immune, Infectious, and Inflammatory Stress , 1995, Annals of the New York Academy of Sciences.

[89]  F. Fawthrop.  Inflammation: Basic Principles and Clinical Correlates , 1993 .

[90]  M. Dallman,et al.  Feast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy Flow , 1993, Frontiers in Neuroendocrinology.

[91]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[92]  V. Laudet,et al.  Evolution of the nuclear receptor gene superfamily. , 1992, The EMBO journal.

[93]  H. Vaudry,et al.  Glucocorticoids, Transmitters and Stress , 1992, British Journal of Psychiatry.

[94]  N. Utsumi,et al.  Comparison between the effects of dexamethasone and indomethacin on bone wound healing. , 1986, Japanese journal of pharmacology.

[95]  M. Reed.  Steroid Hormone Action , 1970, Nature.

[96]  北村 聖.  "The New England Journal of Medicine". , 1962, British medical journal.